You are here: Industry Insights > COVID-19

News List

Inhaled Ampion Advances to Second Group of COVID-19 Patients with Respiratory Distress americanpharmaceuticalreview
November 23, 2020
Ampio Pharmaceuticals announced the second group in the Phase I inhaled Ampion? clinical study is being treated following clearance by the Safety Monitoring Committee (SMC) who found Ampion to be safe and well-tolerated after reviewing the results from ..
US FDA grants EUA to Regeneron’s antibody cocktail for Covid-19 pharmaceutical-technology
November 23, 2020
The US Food and Drug Administration (FDA) has granted Emergency Use Authorisation (EUA) to Regeneron Pharmaceuticals’ antibody cocktail casirivimab and imdevimab for treating patients with mild to moderate Covid-19.
Roche’s arthritis drug shows effectiveness for ill patients in Covid-19 trial pharmaceutical-technology
November 23, 2020
The UK’s Imperial College London has reported that early data from the REMAP-CAP trial showed Roche’s arthritis drug, Actemra (tocilizumab), is expected to reduce deaths and time spent in intensive care in critically ill patients with severe Covid-19.
FDA grants EUA for Lilly and Incyte’s baricitinib for Covid-19 treatment pharmaceutical-technology
November 23, 2020
The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for Eli Lilly and Company and Incyte’s baricitinib in combination with remdesivir in hospitalised patients with Covid-19.
Samsung Biologics Partners with Eli Lilly contractpharma
November 23, 2020
?Samsung Biologics has entered a strategic manufacturing partnership with Eli Lilly to accelerate the global supply for Lilly’s Covid-19 antibody therapies with the ultimate goal of making antibody treatments more globally accessible for patients.
COG-UK Consortium gets ￡12.2 mn for COVID-19 genomic surveillance expresspharma
November 23, 2020
Since its launch in March 2020, COG-UK has generated and made publicly available more than 100,000 SARS-CoV-2 genomes.
ISMMS, Boehringer Ingelheim to test nintedanib for treating pulmonary fibrosis post-COVID-19 infectio expresspharma
November 23, 2020
The primary endpoint of the study is percent change in forced vital capacity, a measurement of lung function, compared to baseline over six months.
WHO takes off remdesivir from prequalification list of medicines for COVID-19 expresspharma
November 23, 2020
It is an official list of medicines used as a benchmark for procurement by developing countries.
AstraZeneca begins trials on antibody cocktail to prevent COVID-19 expresspharma
November 23, 2020
The prophylactic treatment may prove useful in people whose immune systems are weaker or compromised, and who don’t respond to vaccination.
US FDA grants EUA to monoclonal antibodies from Regeneron for COVID-19 treatment expresspharma
November 23, 2020
In a clinical trial, casirivimab and imdevimab, administered together, were shown to reduce COVID-19-related hospitalisation or emergency room visits in patients at high risk for disease progression within 28 days after treatment.